Pages

Wednesday, 6 March 2013

UK National Screening Committee Policy Database

reposted from: http://www.screening.nhs.uk/policydb.php
crabsallover highlightskey pointscomments / links.


This is a complete list of all the UK NSC's policies. Some policies say that screening should be provided for everyone or some people, other policies that screening is not currently recommended.
Note that just because screening is recommended, this does not mean that it is systematically provided across the whole of the UK.
When no good quality research evidence is available, or research has found that screening for a particular condition causes more harm than good, the UK NSC will recommend that routine screening should NOT take place.
All UK NSC policies are reviewed regularly, usually on a 3 year cycle. Read more about the review process.


Only 5 Adult National Screening Programmes are recommended

About 30 Adult National Screening programmes are NOT recommended.


UK Screening / Abdominal aortic aneurysm screening

reposted from: http://www.screening.nhs.uk/publications
crabsallover highlightskey pointscomments / links.

Screening in the UK 2011-12: Policy Review
One adult screening that has been introduced is the 

NHS Abdominal Aortic Aneurysm Screening Programme.


The NHS Abdominal Aortic Aneurysm Screening Programme (NAAASP) aims to reduce
the rate of premature death from ruptured aneurysms by up to 50% in men aged 65
and older. Men are offered an ultrasound scan in their 65th year while older men can
self-refer. Screening aims to reduce deaths by detecting abdominal aortic aneurysm (AAA) early
and offering appropriate surveillance or treatment, usually surgery.

Screening in England 2011-12


  • More than 100,000 men were screened for abdominal aortic aneurysm
  • An estimated 5,000 people in England die every year from ruptured abdominal aortic aneurysms. The programme aims to halve the number of premature deaths from aneurysm rupture amongst men aged 65 and over and has screened 107,000 65-year-old men this year. More than 1,600 [1.5%] were identified as having an aneurysm requiring surveillance or possible treatment. Once the programme has been running for 10 years we expect to have reduced the deaths of men from sudden rupture of the aneurysm by half. That is around 2,000 premature deaths prevented per year. (page 5)

Case study: positive screening tests can lead to difficult choices

Men who have a large aneurysm (5.5cm or larger) detected by the Abdominal Aortic
Aneurysm programme often have to decide not only whether to have it surgically repaired
but also what type of operation to have.

Tony Seccull felt fit and healthy when he was invited for screening but was told that he had a
large aneurysm 5.8cm wide. Tony was referred to vascular surgeon David Durrans to discuss
treatment options. Mr Durrans explained that Tony faced a risk of about one in 10 that his
aneurysm would rupture in the next 12 months. However, aneurysm repair, like all operations,
also carries some risk and around 2% of patients die following surgery. There are two main
aneurysm repair techniques: open surgery and endovascular repair, although not all patients or
all aneurysms are suitable for both.

“I decided I wanted it repaired as soon as possible because I didn’t want it hanging over me,”
said Tony. “Mr Durrans didn’t sell either option but outlined the pros and cons of both and
said it was my decision. I am very glad I was screened because without screening I would not
have been aware of the aneurysm and it could have failed on me at any time. I am also glad I
had the open surgery, even though the recovery is longer, because hopefully it will last for the
rest of my life.” (page 24)

abdominal aortic aneurysm screening

“It is estimated that abdominal aortic aneurysm screening should halve the number of premature deaths from aneurysm ruptures amongst men aged 65 to 74.” Mike Harris, Abdominal Aortic Aneurysm programme

An abdominal aortic aneurysm (AAA) usually produces no symptoms. So most people do not know they have one unless it ruptures (the walls of the blood vessel suddenly tear). A ruptured AAA is a surgical emergency that is fatal in around 80% of cases. In contrast, planned surgery to repair a large aneurysm detected by screening is successful in around 97- 98% of cases. Evidence suggests that up to 2,000 premature deaths from AAA rupture per year will be prevented in 10 years of running the programme. (page 28)

Abdominal aortic aneurysm screening has completely transformed vascular surgery in England. The key was specifying that services were only allowed to offer offer screening if they provided surgery in fewer, larger centres with more experienced surgeons. Previously many people were seen by general surgeons in smaller settings. By bringing expertise together in larger centres, this has improved outcomes and given vascular services a tremendous professional boost.” Robert Sherriff, UK NSC (page 29)



AAA Policy Database


Evidence Supporting the Policy

Screening for abdominal aortic aneurysm, a systematic review in the Cochrane Library Issue 2 2007. See Cosford PA, Leng GC. Screening for abdominal aortic aneurysm. Cochrane Database of Systematic Reviews 2007, issue 2.


... The likelihood of rupture depends on the size of the aneurysm. In the five years following diagnosis rupture occurs in approximately 2% of aneurysms found to be less than 4 cm in diameter and in over 25% of aneurysms larger than 5 cm (Ernst 1993). On this basis currently accepted practice for identified aneurysms is the following (Ballard 1999): • elective surgical repair for large aneurysms, usually taken to be 5.5 cm diameter or larger; • regular (e.g. six monthly) ultrasound surveillance for aneurysms below 5.5 cm diameter, with referral for surgery if the aneurysm grows at >1.0 cm per year or reaches 5.5 cm.

Screening for abdominal aortic aneurysm

An aneurysm is a localised widening (dilation) of an artery. The blood vessel can burst (rupture) because the vessel wall is weakened. Some 5% to 10% of men aged between 65 and 79 years have an abdominal aneurysm in the area of the aorta, the main artery from the heart as it passes through the abdomen. Abdominal aortic aneurysms are often asymptomatic but a rupture is a surgical emergency and often leads to death. An aneurysm larger than 5 cm carries a high risk of rupture. Smaller aneurysms are monitored regularly using ultrasound to see if they are becoming larger. Elective surgical repair of aortic aneurysms aims to prevent death from rupture. The incidence of aortic aneurysm in women as they age is lower than for men.
This review identified four controlled trials involving 127,891 men and 9342 women who were randomly assigned to aortic aneurysm screening using ultrasound or no screening. Only one trial included women. Two of the trials were conducted in the UK, one in Denmark and one in Australia. The results provide evidence of a benefit from screening in men with a strongly significant reduction in deaths from abdominal aortic aneurysm. The odds ratio (OR) for death was 0.60 (range 0.47 to 0.78, three trials) in men aged 65 to 83 years but was not reduced for women. From one trial there was also a decreased incidence of ruptured aneurysm in men but not women.
All-cause mortality was not significantly different between screened and unscreened groups some three to five years after screening, which is to be expected given the relative infrequency of abdominal aortic aneurysm as a cause of death.
Men who had been screened underwent more surgery for abdominal aortic aneurysm (OR 2.03; range 1.59 to 2.59, four trials) but resource analysis appears to demonstrate overall cost effectiveness of screening. There were no data on life expectancy, complications of surgery or quality of life.


A systematic review on screening for abdominal aortic aneurysm, produced by the U.S. Preventive Services Task Force examines the evidence. See:Screening for abdominal aortic aneurysm: a best-evidence systematic review for the U.S. Preventive Services Task Force (2005)

A randomised controlled trial into the effect of abdominal aortic aneurysm screening on mortality in men. See: The Multicentre Aneurysm Screening Study (MASS). Lancet 2002 Nov 16;360(9345):1531-9. PubMed abstract




Related documents

AAA policy review summary (Nov 2005) (PDF document, 80KB, 03/06/11)
Recommendation Screening of men aged 65, with the offer of a single test being made at that age, can be recommended in principle as a programme that meets the criteria and standards of the National Screening Committee.  It is recommended that a programme should start with men aged 65 and would not attempt to recruit men over the age of 65, although an individual over the age of 65 who requested screening would be eligible to be offered a test. It is not recommended that the test be offered to women at present because the mortality from ruptured abdominal aortic aneurysm is at present low.

External review against UK NSC criteria (PDF document, 133KB, 03/06/11)
Rupture of an aneurysm in the abdominal aorta caused about 6,800 deaths in England and Wales in the year 2000, the great majority in men because the age-specific prevalence of the condition is six times greater in men than in women. In men older than 65 years rupture of an abdominal aneurysm is responsible for 2.1% of all deaths and the overall mortality from rupture is between 65% and 85%.

Aneurysms of the abdominal aorta do not regress and are without symptom until they rupture. The mortality rate from aneurysm rupture is due not only to the severity of the injury but also to the speed of its evolution. Of all the deaths attributed to ruptured aneurysms, about half take place before the patient reaches hospital, and of those who reach hospital the mortality rate for emergency treatment is between 30% and 75%.

The cause of abdominal aortic aneurysm is not understood and primary prevention is not possible. As with other vascular diseases efforts to prevent people smoking or to help them stop smoking will influence risk but there are many other reasons to advocate smoking cessation, and at present abdominal aortic aneurysm can be regarded as a disease that cannot be prevented.

21. Public pressure for widening the eligibility criteria, etc, should be anticipated: Screening women is less common. The Chichester study demonstrated no benefit in a randomised trial of 9342 women (published in BJS 2002). Evidence is available on the low prevalence of AAA in younger men and its effect on cost and benefit.



Wikipedia


Epidemiology

In the United Kingdom the rate of AAA in Caucasian men older than 65 years is about 4.7%[68]
There are 15,000 deaths yearly in the U.S. secondary to AAA rupture.[69] The frequency varies strongly between males and females. The peak incidence is among males around 70 years of age, the prevalence among males over 60 years totals 2-6%. The frequency is much higher in smokers than in non-smokers (8:1), and the risk decreases slowly after smoking cessation.[70] Other risk factors include hypertension and male sex.[8] In the U.S., the incidence of AAA is 2-4% in the adult population.[6] AAA is 4-6 times more common in male siblings of known patients, with a risk of 20-30%.[71] Rupture of the AAA occurs in 1-3% of men aged 65 or more, the mortality is 70-95%.[3]

With the recent advancements in AAA research, AAA is ranked as the 13th leading cause of death in the US and the 10th leading cause of death in men over the age of 55 years.

Post-mortem studies have suggested that ninety-five percent of deaths from ruptured AAA occur at or above age 65; Eur J Vasc Endovasc Surg 21, 535–540 (2001) doi:10.1053/ejvs.2001.1368
cgs file: scott-AAA.pdf

UK health performance: findings of the Global Burden of Disease Study 2010

reposted from: The Lancet (full text - free article) via Cancer Research UK

crabsallover highlightskey pointscomments / links.

Funding: Bill & Melinda Gates Foundation.

Improvements in the UK's health lag behind many other developed nations, a study published in The Lancet has revealed.
Although life expectancy of Britons has increased thanks to six decades of universal healthcare, vastly increased health spending and widespread anti-tobacco initiatives, the UK has failed to keep pace with the 14 other original members of the European Union, Australia, Canada, Norway, and the USA over the past 20 years
While average UK life expectancy has increased by 4.2 years over the last two decades, the nation's premature death rates have dropped at a slower rate than the rest of the other countries.
Using data from the 2010 Global Burden of Disease study, a team of international experts led by Dr Chris Murray, from the University of Washington's Institute for Health Metrics and Evaluation, analysed patterns of ill health and death in the UK. They then ranked them against other high-income countries with similar levels of health expenditure in 1990 and 2010.
Smoking is a large factor in the UK's poor relative performance, alongside alcohol, drug abuse and obesity, with doctors calling for a more joined-up health policy to help educate the public about health lifestyles.
The eight leading causes of death in the UK have remained relatively consistent over the last 20 years, with ischemic heart disease, chronic obstructive pulmonary disease (COPD), stroke, lung cancer and lower respiratory infections continuing to top the list.
Sarah Woolnough, Cancer Research UK's executive director of policy and information, said the findings underlined the need for action.
"We know that smoking, being overweight or obese, poor diet and alcohol consumption all increase the risk of developing cancer," she said.
"Over 40 per cent of cancers in the UK are preventable; of these, tobacco is the single largest cause of cancer responsible for over 60,000 cases in the UK. It is sadly not surprising that lung cancer remains in the top five causes of death in the UK.
That, said Woolnough, highlighted the need for improved public health and early intervention to tackle premature mortality, and to "achieve mortality rates on a par with the best countries in the world".
"As part of this, we are urging the Government to introduce standardised packaging of tobacco, which would make tobacco less attractive, and help prevent a further generation of young people from starting to smoke," she added.
Dr Edmund Jessop, from the UK Faculty of Public Health, said that despite the overall findings, the UK had done "very well" in some areas over the last two decades, citing reduced mortality rates, improved diet and a drop in disability-adjusted life-years.
This meant that the UK had seen significantly lower premature mortality from diabetes, road injuries, liver cancer and chronic kidney diseases
He also pointed out that the UK has some of the strongest tobacco control policies in Europe.
Copyright Press Association 2013

Reference

  • Murray C.J., Richards M.A., Newton J.N., Fenton K.A., Anderson H.R., Atkinson C., Bennett D., Bernabé E., Blencowe H. & Bourne R. & (2013). UK health performance: findings of the Global Burden of Disease Study 2010, The Lancet, DOI: 





Figure 3: Age-standardised YLLs relative to comparator countries and ranking by cause in (A) 1990 and (B) 2010
Numbers in cells indicate the ranks of each country for each cause, with 1 representing the best performing country. Countries have been sorted on the basis of age-standardised all-cause YLLs for that year. Causes are ordered by the 30 leading causes of YLLs in the UK. Colours indicate whether the age-standardised YLL rate for the country is significantly lower (green), higher (red), or indistinguishable (yellow) from the mean age-standardised YLL rate across comparator countries, with 95% confidence. YLLs=years of life lost. COPD=chronic obstructive pulmonary disease.



Figure 4
YLDs in the UK by cause and age in 2010
YLDs=years lived with disability.


Figure 7
Burden of disease attributable to 20 leading risk factors for both sexes in 2010, expressed as a percentage of UK disability-adjusted life-years
The negative percentage for alcohol is the protective effect of mild alcohol use on ischaemic heart disease and diabetes.


Tuesday, 5 March 2013

LifeLineScreening.co.uk tests - Heart, Aorta, Artery, Stroke/Carotid

Update: 21/3/13 Today had my Abdominal Aorta screened for Abdominal Aorta Aneurism (AAA) with Life Line Screening. Result: 2.2cm (top of aorta) to 1.8cm (bottom of aorta) was normal. The pressure of the scanner on the bottom of my rib cage was intense! I've still got a mild bruise a day later. The Sonographer was not very fluent in English and used technical language for the parts of the body that I didn't understand and had to question him on the meaning of the terms.

But it was worth it to know I've not got any Abdominal Aorta Aneurism ... a potentially fatal condition.

Next up, I'm checking for Bowel Cancer Screening which is offered at 60 years for free on the NHS (I'm 56 so not eligible for 4 years).

5th March 2013: Through the post I was targeted by LifeLineScreening.co.uk to take the Vascular and Heart Rhythm tests for £149. I'm checking with my doctor / online to see if these tests are worthwhile for me and whether they are available on the NHS.

Care Quality Commission on Life Line Screening and CQC report.


UK National Screening Committee has advice on private company screening; 3 page brochure.

For another £60 (£209) I could have opted for these extra tests 1) Complete Lipid Panel test* 2) Type 2 Diabetes test** 3) Coronary Heart Disease Risk Analysis (Framingham chart uses 1) & 2) data but QRISK is replacing it in the UK).  LifeLineScreening Price List  here.

*: available from my NHS Doctor for free

Vascular and Heart Rhythm
£149Reg. £280
SAVE £131!

1) Overview of Heart Rhythm Screening (Atrial Fibrillation) 

This test uses electrocardiogram readings to detect irregular heart rhythm (atrial fibrillation) at the time of screening. Atrial fibrillation increases the risk of stroke 5-fold.

How the screening is performed:

You will be asked to lie on your back on the examination table and electrode stickers will be placed on your collar bones or wrists and ankles. A small device then connects the electrodes to the electrocardiogram machine which then takes your reading.

2) Overview of enlarging of the Aorta Test (Abdominal Aortic Aneurysm) 

Wikipedia
This is an ultrasound test used to measure the size of your aorta, your main blood vessel, in the abdomen. Over time, the aorta can become enlarged and if it swells too much it could rupture.

How the screening is performed:

You will be asked to lie on your back on the examination table and the Sonographer will move a transducer over your abdomen to measure the size of your aorta.



Scans are normally offered via the NHS only when symptoms become present - although currently the NHS is piloting an Abdominal Aortic Aneurysm screening programme [say LifeLineScreening] [what is AAA?], which is scheduled to be fully rolled out across England in 2013 [to over 65s ONLY]  . 

What about men under 65? The NHS programme is offered to men aged 65 and over because 95 per cent of ruptured AAA occur in this group. There is no evidence to show that inviting men who are younger than 65 for screening as part of a population-based screening programme would deliver major benefits [a matter of economics/health benefits??]6,000 die of ruptured AAA in UK, ie 300 with AAA under 65 die each year.

The risk of developing an AAA also increases through close family history. If you have a close relative - brother, sister or parent - who has, or has had, an AAA you can receive an ultrasound scan at an appropriate age under existing NHS procedures and should speak to your GP to discuss a referral. 

3) Overview of the Artery Hardening Test (Peripheral Arterial Disease) 

Wikipedia
This test uses ultrasound and blood pressure measurements to check for peripheral arterial disease (hardening of the arteries) in the lower extremities. Peripheral Arterial Disease increases your risk of heart attack or stroke by 2 to 6 times and affects 1 in 6 people over the age of 55.

How the screening is performed:

Pressure cuffs will be placed around your upper arms and ankles and a small ultrasound device is used to measure the systolic blood pressure in your limbs.

4) Overview of Stroke Risk Screening (Stroke/Carotid Ultrasound) 

Wikipedia | National Institutes of Health | NHS Choices | Stroke Prevention
This screening uses ultrasound to look inside your carotid arteries for buildup of fatty plaque. Excess plaque build in your carotid arteries can restrict the flow of blood to your brain and cause a stroke. 

How the screening is performed: 

You will be asked to lie on your back on the examination table. The Sonographer will then apply some gel to your neck and use a transducer to create images of your carotid arteries in order to assess the rate of blood flow within them.

Thursday, 28 February 2013

Roche Accu-Chek - Glucose meter




crabsallover highlightskey pointscomments / links.
Reposted from: Accu-chek & Accu-chek Aviva Nano Blood Glucose Meter

Excellent portable glucose meter. 10 test strips and 12 Lancets plus all the kit. View the demo.

Crabsallover 5.8 mmol/L